Znanstveni rad - Pismo
The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study
Psychiatry Research, 279 (2019); 389-390. https://doi.org/10.1016/j.psychres.2019.04.028


Citirajte ovaj rad

Živković, M., Mihaljević Peleš, A., Muck Šeler, D., Šagud, M., Ganoci, L., Vlatković, S. ... Pivac, N. (2019). The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study. Psychiatry Research, 279., 389-390. doi: 10.1016/j.psychres.2019.04.028

Živković, Maja, et al. "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study." Psychiatry Research, vol. 279, 2019, str. 389-390. https://doi.org/10.1016/j.psychres.2019.04.028

Živković, Maja, Alma Mihaljević Peleš, Dorotea Muck Šeler, Marina Šagud, Lana Ganoci, Suzana Vlatković, Matea Nikolac Perković, Lucija Tudor, Nada Božina i Nela Pivac. "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study." Psychiatry Research 279 (2019): 389-390. https://doi.org/10.1016/j.psychres.2019.04.028

Živković, M., et al. (2019) 'The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study', Psychiatry Research, 279, str. 389-390. doi: 10.1016/j.psychres.2019.04.028

Živković M, Mihaljević Peleš A, Muck Šeler D, Šagud M, Ganoci L, Vlatković S, i sur.. The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study. Psychiatry Research [Internet]. 09.2019. [pristupljeno 14.04.2024.];279:389-390. doi: 10.1016/j.psychres.2019.04.028

M. Živković, et al., "The lack of association between COMT rs4680 polymorphism and symptomatic remission to olanzapine monotherapy in male schizophrenic patients: A longitudinal study", Psychiatry Research, vol. 279, str. 389-390, Rujan 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:203373. [Citirano: 14.04.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.